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Significance of blood aspiration in carotid artery
stenting with Angioguard XP
Takashi Mizobe, MD, Mitsugu Nakamura, MD, Yasuhiko Motooka, MD, Yoshito Uchihashi, MD,
Masahiro Sugihara, MD, and Shigetaka Okamoto, MD, Himeji, Japan
Background and Purpose: In some patients, angiographic flow impairment is observed during carotid artery stenting
(CAS) using Angioguard XP (AGXP), resulting in neurological symptoms. CAS was thus modified to improve clinical
outcome.
Methods: Ninety-seven patients were treated with CAS using AGXP from January 2008 to October 2009. In period I
(January-December 2008; n  53), blood aspirations were performed only in no-flow cases. In period II (January-
October 2009; n 44), blood aspirations were performed in no-flow and slow-flow cases. Clinical outcome, detection of
microembolic lesions on diffusion-weighted imaging (DWI) and flow impairment during CAS were examined between
these two periods before and after modifying the CAS procedure.
Results:Periprocedural transient ischemic attacks occurred in 10 patients (18.9%) and one patient (2.27%) in periods I and
II, respectively (P  .018). Minor and major strokes were observed in two patients in each period (P  .849). New
ipsilateral DWI lesions were detected in 25 patients (47.2%) and 11 patients (25.0%) in periods I and II, respectively (P 
.024). Among 18 slow-flow cases, new DWI lesions were detected in one patient (9.09%) and five patients (71.4%) with
(n  11) and without (n  7) blood aspirations, respectively (P  .013). Neurological symptoms were observed only in
three of seven patients (42.9%) without aspirations, compared to one of 11 patients (9.1%) with aspirations (P  .043).
Conclusion: Postoperative symptomatic stroke and new DWI lesions are significantly associated with blood flow
impairment during CAS using AGXP. When flow impairment occurs, blood aspiration should be performed. (J Vasc
Surg 2011;53:1478-84.)
M
H
C
t
(
c
p
s
s
a
h
h
d
a
c
s
s
p
(
2
m
J
i
n
c
dCarotid artery stenting (CAS) has been established as
an alternative procedure to carotid endarterectomy (CEA)
since the Stenting and Angioplasty with Protection in Pa-
tients at High Risk for Endarterectomy (SAPPHIRE) tri-
als,1,2 but embolic lesions detected on diffusion-weighted
imaging (DWI) may occur more frequently in cases of CAS
than in those of CEA. Whereas these lesions are almost
silent, they can be associated with cognitive impairment
found on neuropsychometric examination.3-6
Whereas CAS is performed using the Angioguard XP
(AGXP; Cordis Endovascular, Miami Lakes, Fla), which is
the only approved device for use during CAS in the Japa-
nese Health Insurance System, angiographic flow impair-
ment proximal to the filter may result in new cerebral
embolic lesions and symptomatic stroke.7,8 The clinical
impact of blood aspiration on flow impairment is assessed
by evaluating postprocedural symptomatic stroke and new
embolic lesions on DWI, which are associated with flow
impairment.
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Patient population. Ninety-seven patients in the
yogo Brain and Heart Center at Himeji were treated with
AS using AGXP from January 2008 to October 2009. A
otal of 82men and 15women, with amean age of 73.2 years
range, 57-85 years) were enrolled in the study. Based on the
riteria used in the SAPPHIRE trials, CAS was indicated for
atients having a high-risk factor for CEA and over 50%
ymptomatic stenosis or over 80% asymptomatic stenosis;
tenosiswas determinedusing theNorthAmerican Symptom-
tic Carotid Endarterectomy Trial protocol criteria. CEA
igh-risk factors include previousCEA, previous neck surgery,
igh level C1 or C2 lesions, and severe active coronary artery
isease (CAD). A carotid stenosis was considered symptom-
tic if the patient had experienced an ipsilateral ocular or
erebral ischemic eventwithin 6months before the start of the
tudy. According to this criteria, 31 patients were labeled
ymptomatic and 66 asymptomatic.
The patients were grouped into two time periods: 53
atients (43 men, 10 women) with a mean age of 72.8 years
range, 57-84 years) were treated from January to December
008 (period I), and 44 patients (39men, five women) with a
ean age of 73.8 years (range, 60-84 years) were treated from
anuary to October 2009 (period II). The clinical character-
stics of the patients are presented in Table I.
Cerebral angiograms were evaluated for a definitive diag-
osis of the lesions. Preoperative and postoperative degrees of
arotid stenosis, lesion length, and the number of stents were
etermined using the angiographic data are presented in
able I.
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Volume 53, Number 6 Mizobe et al 1479Two days before CAS, magnetic resonance imaging
(MRI) was routinely performed using a 3T MR Imager
(Intra; Philips Medical Systems, Best, The Netherlands)
followed by sequencing of T1-weighted and T2-weighted
images, fluid-attenuated inversion recovery imaging, DWI,
and time-of-flight MR angiography.
Written informed consent for diagnostic and interven-
tional procedures was obtained from each patient.
Data collection. Clinical, radiological, and procedural
data were obtained for each patient. Clinical variables in-
cluded the following: age, gender, hypertension (blood
pressure 140/90 mm Hg measured repeatedly or pres-
ence of antihypertensive drugs), diabetes mellitus (HbA1c
6.5%, fasting blood glucose 120 mmol/L or presence
of antidiabetic drugs), hyperlipidemia (fasting serum cho-
lesterol levels 220 mmol/L), and CAD (history of an-
gina, myocardial infarction, percutaneous transluminal an-
gioplasty, or surgery). Radiological variables were
established by the evaluation of postprocedural MRI and
digital subtraction angiography (DSA). These variables in-
cluded the number of postprocedural embolic lesions in
DWI, grade of stenosis, and the presence of ulcerated
Table I. Clinical and lesion characteristics in both groups
of patients
Period I Period II
(n  53) (n  44) P value
Clinical
characteristics
Men 43 (81.1%) 39 (88.6%) .31
Age (years) 72.8  6.3 73.8  7.0 .42
HTN 47 (88.7%) 32 (72.7%) .045a
DM 25 (47.2%) 20 (45.5%) .87
Hyperlipidemia 20 (37.7%) 19 (43.2%) .74
CAD 21 (39.6%) 19 (43.2%) .73
Symptomatic 14 (26.4%) 17 (38.7%) .2
History of TIA 4 (7.5%) 9 (20.5%) .06
History of cerebral
infarction
19 (35.8%) 13 (29.5%) .52
Lesion characteristics
Degree of stenosis
(%)
Pre-CAS 80  9 81  11 .550
Post-CAS 6  8 9  8 .07
Lesion length
(mm %)
19.7  11.2 19.9  12.9 .96
Ulceration 23 (43.4%) 11 (25.0%) .060
Procedural
characteristics
Number of stents
used
1.16  0.37 1.27  0.60 .27
Fluoroscopy time
(minutes)
25.7  3.00 25.1  2.70 .29
CAD, Coronary artery disease; CAS, carotid artery stenting; DM, diabetes
mellitus; HTN, hypertension; TIA, transient ischemic attack.
Continuous variables are shown as means with SDs in parentheses.
Categorical variables are shown as frequencies with percentages in paren-
theses.
aP  .05.plaques on both DSA and ultrasonography. Lesion ulcer- ftion was defined as a recess having a depth of 2 mm or
ore from the plaque surface.
Carotid artery stenting. Administration of two types
f oral antiplatelet agents, including aspirin (100 mg, n 
7) in combination with clopidogrel (75 mg, n  95),
ilostazol (200 mg, n 1), or ticlopidine (200 mg, n 1)
as initiated at least 4 days before CAS. General anesthesia
as induced for 13 patients with occlusion of the contralat-
ral carotid artery and poor contralateral vessels.
After intravenous administration of 100 IU/kg heparin
o achieve an activated clotting time (ACT) of over 300
econds, an 8F guiding catheter was inserted through an
F-long sheath in the femoral artery and was placed in the
ommon carotid artery. The lesions were bypassed using
GXP and the filter was opened. Predilatation with 3.0-
m-diameter balloon was indicated for the lesions with
igh stenosis rate or calcification in 56 of 97 patients
57.7%). This was followed by implantation of the
RECISE stent (Cordis Endovascular), with postdilatation
f lesions for complete recovery. Carotid flow was angio-
raphically after each step with manual injections (4 mL, 2
L/s).
Flow impairment was determined on an angiogram
aken immediately after postdilatation. The thrombolysis in
yocardial infarction (TIMI) flow grade classification for
he coronary artery was modified9 to define the flow im-
airment in the carotid artery:
● No flow was defined as flow arrest corresponding to
grade 0 in TIMI, or that the contrast agent could go
through the filter but could not reach the middle
cerebral artery.
● Slow flow was defined as flow reduction with contri-
bution to the middle cerebral artery, corresponding to
grade 2 in TIMI.
● Normal flow corresponded to grade 3 in TIMI.
Where flow impairment was observed, multiple aspira-
ions of the blood column proximal to the filter were
erformed using the Export aspiration catheter (Medtronic,
inneapolis, Minn) and a 30-mL syringe, around the distal
dge of the stent proximal to the filter, which was at least 20
m away from the filter basket. Aspirated blood was fil-
ered through the four-folded two-ply gauze. There was
sually some debris left on the gauze. Blood aspirations
ere performed until debris could not be macroscopically
bserved. Neurological symptoms and vital signs were
onitored during the multiple aspirations in each patient
y the operator and the assistants. The filter was finally
etrieved using a capture sheath. Multiple aspirations were
ndicated for no-flow cases during period I and for both
o-flow and slow-flow cases during period II.
An MRI was routinely performed about 48 hours after
AS to detect new ischemic lesions, not seen on the pre-
AS MRI.
Definitions of complications after carotid artery
tenting. The primary clinical outcome of this study was
valuated with respect to incidence death, myocardial in-
arction, or neurological symptoms, including transient
I
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June 20111480 Mizobe et alischemic attack (TIA) and minor and major stroke within
30 days after CAS. Each patient was neurologically exam-
ined prior to CAS, the day after CAS, and at day 30. The
definitions of neurological complications that occurred
within the first 24 hours and within the next 30 days after
CAS were defined as follows based on a previous study by
Mathur10:
● TIA: any new neurological deficit that was resolved
within 24 hours.
● Minor stroke: any new neurological deficit that per-
sisted for more than 24 hours and was resolved com-
pletely within 30 days.
● Major stroke: any new neurological deficit that per-
sisted after 30 days and increased the modified Rank-
ing Scale 1 point.
Neurological deficit, which emerged predilatation or
postdilatation and disappeared after deflation of the bal-
loon, was not defined as TIA.
Statistical analysis. Continuous and categorical vari-
ables were reported as means with SDs and frequencies with
percentages, respectively. The clinical characteristics and
procedural and radiological variables were compared be-
tween patients in periods I and II and between patients with
flow impairment and those with normal flow. The compar-
isons were made using the independent samples t test, 2
test with Yates correction, or the Fisher exact test. Among
slow-flow cases, patients with multiple aspirations were
compared to those with no aspiration using the 2 test with
Yates correction or the Fisher exact test. A P value less than
.05 was considered statistically significant.
RESULTS
Apart from hypertension, no significant differences
Table II. Outcomes of neurological symptoms and DWI
in each period
Neurological symptoms
TIA Minor/maj
Period I
Normal flow (n  36) 3 (8.33%) 1 (2.78
Slow flow (n  7) 3 (42.9%) 0
No flow (n  10) 4 (40.0%) 1 (10.0
Subtotal (n  53) 10 (18.9%)a 2 (3.77
Period II
Normal flow (n  29) 0 2 (6.90
Slow flow (n  11) 0 0
No flow (n  4) 1 (25.0%) 0
Subtotal n  44 1 (2.27%)a 2 (4.55
CAS, Carotid artery stenting; DWI, diffusion-weighted imaging; TIA, trans
Continuous variables are shown as means with SDs in parentheses.
Categorical variables are shown as frequencies with percentages in parenthe
TIA: any new neurological deficit that was resolved within 24 hours.
Minor stroke: any new neurological deficit that persisted for more than 24
Major stroke: any new neurological deficit that persisted after 30 days and i
aP  .010.
bP  .006.
cP  .024.were observed in patients and lesional characteristics (Table M) between the two time periods. No patient died or suf-
ered myocardial infarction for 30 days after CAS.
Neurological symptoms were observed in 15 patients:
2 patients during period I, which included 10 TIAs, one
inor stroke, and one major stroke, and three patients
uring period II, which included one TIA and two minor
trokes (P  .35; Table II). Incidence of TIA was signifi-
antly reduced in period II (P  .010; Table II). In period
, positive DWI lesions were seen in five of 10 no-flow cases
50%), five of seven slow-flow cases (71.4%), and 15 of 36
ormal-flow cases (41.7%; Table II). In period II, positive
WI lesions were seen in one of four no-flow cases (25%),
ne of 11 slow-flow cases (9.1%), and nine of 29 normal-
ow cases (31.0%; Table II). Periprocedural DWI lesions in
low-flow cases were significantly reduced in period II (P
006; Table II).
TIA was resolved within 30 minutes after each CAS
rocedure. All three patients with minor strokes experi-
nced upper extremity numbness for 1 week after the
rocedure. One patient with major stroke experienced left
emiparesis, which worsened from grade 0 to grade 2 on
he modified Rankin scale after 1 month. Neurological
ymptoms were observed in 15 patients; after postdilatation
n 10 patients, after placement of the stent in one patient,
nd after predilatation in one patient. In the remaining
hree patients, two complained of numbness in their upper
imbs and one complained of a mild disturbance in finger
ovement after CAS. The exact time of onset was uncer-
ain.
Total fluoroscopy times for the procedure were 25.9
.2 minutes and 25.2  3.1 minutes in flow impairment
nd normal flow, respectively (P  .77; Table III). The
ean time between the CAS procedure and the follow-up
s after CAS in slow-flow, no-flow, and normal-flow cases
DWI lesions
oke Positive on DWI Mean number of microemboli
15 (41.7%) 1.31  2.52
5 (71.4%) 2.71  2.56b
5 (50.0%) 3.00  5.50
25 (47.2%) 1.75  3.21c
9 (31.0%) 1.28  2.34
1 (9.09%) 0.18  0.60b
1 (25.0%) 0
11 (25.0%) 0.89  1.99c
chemic attack.
and was resolved completely within 30 days.
ed the modified ranking scale 1 point.lesion
or str
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ncreasRI was 51 hours.
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Volume 53, Number 6 Mizobe et al 1481Eleven of 15 patients (73.3%) with neurological symp-
toms had postoperative DWI lesions. New postoperative
lesions on DWI were detected in 25 patients (47.2%)
during period I and 11 patients (25.0%) during period II
(Table II), a number significantly lower than that in period
I (P .024). The number of lesions were 1.75 3.21 and
0.89  1.99 in periods I and II, respectively (P  .131).
Overall, 12 of 36 patients (33.3%) with postoperative
DWI lesions had neurological symptoms. The number of
lesions were 5.08  4.77 in patients with neurological
symptoms and 2.65  2.08 in those without symptoms,
respectively (P .04) and 1.45 1.75 in the patients with
TIA, and 10.8  4.65 in patients with minor or major
stroke, respectively (P  .0001). Increased lesion load was
significantly related to neurological symptoms. Out of 36
patients with DWI lesions, 33 patients (92%) showed ipsi-
lateral lesions, whereas three patients (8%) had bilateral
lesions. There were no lesions observed in the vertebral
artery region. Occlusion of the main cerebral branches
could not be observed on post-CAS angiograms in all
patients.
On the other hand, three of 61 patients (4.92%) with-
Table III. Clinical and lesion characteristics of slow-flow
or no-flow and normal-flow cases
Slow or no flow Normal flow
(n  32) (n  65) P value
Clinical
characteristics
Men 31 (96.9%) 51 (78.5%) .018a
Age (years) 73.3  6.1 73.3  6.9 .998
HTN 26 (81.3%) 53 (81.5%) .973
DM 14 (43.8%) 31 (47.7%) .718
Hyperlipidemia 12 (37.5%) 27 (41.5%) .872
CAD 10 (31.3%) 30 (46.2%) .164
Symptomatic 13 (40.6%) 18 (27.7%) .203
History of TIA 4 (12.5%) 9 (13.8%) .857
History of cerebral
infarction
13 (40.6%) 19 (29.2%) .266
Lesion characteristics
Degree of stenosis
(%)
Pre-CAS 83  10 79  10 .090
Post-CAS 7  7 8  8 .813
Lesion length
(mm)
22.7  16.4 18.4  8.8 .094
Ulceration 16 (50.0%) 18 (27.7%) .031a
Procedural
characteristics
Number of stents
used
1.28  0.68 1.18  0.39 .378
Fluoroscopy time
(minutes)
25.9  2.2 25.2  3.1 .772
CAD, Coronary artery disease; CAS, carotid artery stenting; DM, diabetes
mellitus; HTN, hypertension; TIA, transient ischemic attack.
Continuous variables are shown as means with SDs in parentheses.
Categorical variables are shown as frequencies with percentages in paren-
theses.
aP  .05.out postoperative DWI lesions had neurological symptoms bP  .05). In these cases, neurological symptoms emerged
ith the no-flow phenomenon and disappeared after the
AS procedure. The symptoms were probably associated
ith intolerance to the reduction of cerebral blood flow.
All of 32 cases of flow impairment duringCAS occurred
ostdilatation; 17 of 53 (32.1%) in period I and 15 of 44
34.1%) in period II. Clinical and lesional characteristics of
o-flow or slow-flow and normal-flow cases are shown in
able III. Male gender (P  .018) and lesion ulceration
P  .031) were significantly associated with asymptom-
tic flow impairment. As shown in Table IV, nine of 32
atients (28.1%) with flow impairment had neurological
ymptoms (eight TIAs and one major stroke), and six of
5 patients (9.23%) with normal flow had neurological
ymptoms (three TIAs and three minor strokes), indicating
hat flow impairment was significantly related to neurolog-
cal symptoms (P  .007).
Out of 10 patients who underwent CAS within 1
onth of the last reported symptoms, six patients (60%)
howed DWI lesions. Out of 21 patients who underwent
AS after 1 month of the last reported symptoms, four
atients (19.0%) showed DWI lesions (P  .040).
Slow flow was observed in seven and 11 patients during
eriods I and II, respectively (Table II). No neurological
ymptoms were observed in 11 patients with multiple aspi-
ations (period II), but three of seven patients (42.9%)
ithout aspirations had TIAs (Table V; P  .043). New
WI lesions were observed in one of 11 patients (9.09%)
ith multiple aspirations and five of seven patients (71.4%)
ithout aspirations (P  .013). We could observe some
acroscopic debris in the aspirated blood from all patients
ith slow flow during CAS (Fig 1). The mean number of
able IV. Radiological and neurological symptoms after
AS in slow-flow or no-flow and normal-flow cases
Slow or no flow Normal flow
(n  32) (n  65) P value
utcomes
resence of ipsilateral
microemboli 12 (37.5%) 24 (36.9%) .957
ean number of
microemboli 1.50  3.34 1.29  2.43 .728
eurological
symptoms 9 (28.1%) 6 (9.23%) .019a
IA 8 (25.0%) 3 (4.62%) .005a
troke 1 (3.13%) 3 (4.62%) .845
inor stroke 0 3 (4.62%) .221
ajor stroke 1 (3.13%) 0 .155
AS, Carotid artery stenting; TIA, transient ischemic attack.
ontinuous variables are shown as means with SDs in parentheses.
ategorical variables are shown as frequencies with percentages in paren-
heses.
IA: any new neurological deficit that was resolved within 24 hours.
inor stroke: any new neurological deficit that persisted for more than 24
ours and was resolved completely within 30 days.
ajor stroke: any new neurological deficit that persisted after 30 days and
ncreased the modified ranking scale 1 point.
P  .05.lood aspirations was 7.7 (range, 4-17) in slow-flow cases.
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CAS has been used as an alternative procedure to CEA
worldwide since the SAPPHIRE trial proved the superior-
ity of CAS over CEA. Major adverse events (MAEs) within
30 days, including minor and major strokes, death, or
myocardial infarction, have an incidence of 4.8%1,2 in CAS
cases. In our study, MAEs were observed in four of 97
patients (4.12%). However, TIA, the most frequent neuro-
logical symptom observed in our study, which was not
described in the SAPPHIRE trial, was the reason for the
overall high incidence rate of neurological symptoms of
22.6% and 6.8% in period I and period II, respectively. TIAs
were observed more frequently in flow impairment cases
than in normal-flow cases in period I. Amajority of peripro-
cedural DWI lesions remain clinically silent, but neuropsy-
chometric examination revealed cognitive dysfunction in
some of the clinically silent cases.6,11,12 Moreover, in-
creased lesion load may be responsible for the clinical
impact.13,14
Lesion ulceration and masculine gender were signifi-
cant factors helping in the prediction of flow impairment.
Lesion ulceration was related to vulnerable plaque, which is
an independent risk factor for stroke,15 and can be detected
by advanced assessment on ultrasonography or MRI.16,17
Lesion length, the percentage of stenosis, and the number
of stents used were not related to the incidence of flow
impairment. This suggests that the flow impairment may be
associated with the vulnerability of the carotid plaque. The
relation between masculine gender and flow impairment
was uncertain, but 69 of 82 men (84%) were smokers and
Table V. Radiological and neurological symptoms after
CAS in slow-flow cases with multiple or no aspiration
Multiple
aspirations No aspiration
(n  11) (n  7) P value
Outcomes
Presence of ipsilateral
microemboli 1 (9.09%) 5 (71.4%) .013a
Mean number of
microemboli 0.18  0.60 2.71  2.56 .006a
Neurological
symptoms 0 3 (42.9%) .043a
TIA 0 3 (42.9%) .043a
Stroke 0 0 n.s.
Minor stroke 0 0 n.s.
Major stroke 0 0 n.s.
CAS, Carotid artery stenting; n.s., not significant; TIA, transient ischemic
attack.
Continuous variables are shown as means with SDs in parentheses.
Categorical variables are shown as frequencies with percentages in parentheses.
TIA: any new neurological deficit that was resolved within 24 hours.
Minor stroke: any new neurological deficit that persisted for more than 24
hours and was resolved completely within 30 days.
Major stroke: any new neurological deficit that persisted after 30 days and
increased the modified ranking scale 1 point.
aP  .05.none of the women were smokers; this finding indicates flhat smoking is a risk factor for stroke and is related to
ulnerable plaque, as Redgrave et al18 demonstrated.
This study demonstrates a significant correlation between
ow impairment and the occurrence of post-CAS neurologi-
al symptoms and DWI lesions. Furthermore, the number of
WI lesions significantly correlates with the severity of neu-
ological symptoms. In period I, TIA occurred in 42.9% of
low-flow cases, which was higher compared to 40.0% in
o-flow cases. In the same period, the frequency of DWI
esions was 71.4% in slow-flow cases, which was unexpectedly
igher compared to 50.0% in no-flow cases. Based on these
esults, we modified the CAS procedures for period II, em-
hasizing on blood aspiration for slow-flow cases. As a result,
lood aspiration reduced the frequency of neurological symp-
oms and DWI lesions in slow-flow cases.
Flow impairment during CAS was observed in 32 of 97
atients (33.0%) in this study, which also shows the rate of
ow impairment ranging from 10.1% to 40.0% with various
lter devices.7,8,19 In this study, neurological symptoms
nd DWI lesions were observed more frequently in no-flow
r slow-flow cases than in normal-flow cases. It has been
reviously reported by Casserly et al7 that patients with
low flow are at higher risk of stroke than patients with
ormal flow (9.5% vs 1.7%).
The filter should ideally capture all the debris coming
rom the arterial wall and the various kinds of plaques, but
t has several limitations. Instances where the volume of
ebris exceeds the filter’s volume, a no-flow phenomenon
ccurs and the excess debris floats proximal to the filter in
he carotid artery, which then requires removal by blood
spiration. In slow-flow cases, where the filter pores are
ncompletely occluded by the captured debris, the blood
ow is disturbed but maintained. When the volume of the
ebris does not exceed that of the filter basket, the filter can
apture all debris, which can be retrieved without aspira-
ion. However, this explanation is only theoretic and can-
ot support the results of this study, including the high
requency of post-CAS neurological symptoms and DWI
esions in slow-flow cases during period I. Hence, a more
ractical approach is required.
The second limitation is the capture ability with respect
o different kinds of debris. While rinsing the aspirated
lood with heparinized saline on a gauze piece, two differ-
nt kinds of debris were macroscopically observed: (1)
mall solid fragments corresponding to the vascular intima
nd parts of hard plaque and (2) yellowish-white fragile
aterial, originating from the ruptured contents of the
ipid-rich soft plaques (Fig 1). While solid fragments could
e found within the filter basket (Fig 2), fragile materials
ere usually found on the gauze, because the size of the
olid fragments was larger than the size of the fragile
aterial. One of the explanations about the material is that
t could not be debris but thrombus formed in stagnated
lood flow proximal to the filter. But to maintain the ACT,
300 seconds with heparinization and almost the same
uoroscopy time between no-flow or slow-flow and normal
ow, do not support the explanation.
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Volume 53, Number 6 Mizobe et al 1483Our results indicate that the AGXPmay be incapable of
capturing the fragile debris floating within the internal
carotid artery in slow-flow cases. As a result, failure to
perform blood aspiration in the period I cases led to a
higher frequency of post-CAS neurological symptoms and
DWI lesions, the frequency of which decreased with blood
aspiration in period II. According to Maulex et al,5 the
presence of debris captured by the filter device could not be
significantly related to new DWI lesions after CAS, indicat-
ing the presence of some different kinds of debris in the
internal carotid artery. Casserly et al7 examined the aspi-
rated blood in flow impairment cases and found that the
debris consisted of lipid-laden macrophages, cholesterol
clefts, and fibrin materials, which could correspond to the
fragile materials in our study, indicating that multiple blood
aspirations should be performed in flow impairment cases.
Fig 1. Debris left on the gauze from aspirated blood in
this case. A, Debris (arrow) was found four times in six
(arrow) was viscous and fragile.
Fig 2. Captured debris in the filter of the Angioguard XP. The
appearance of debris was solid.A detailed examination of other prospective filter deviceshould be carried out to assess their capture volume and
apture ability for various kinds of debris.
ONCLUSION
Flow impairment could be caused by the debris origi-
ating from the core of carotid plaques. Some kinds of
ebris could not be captured completely with the AGXP
lter, which resulted in neurological symptoms and DWI
esions. Multiple blood aspirations proximal to the filter in
ase of flow impairment significantly reduced perioperative
IAs and new DWI lesions after CAS with the AGXP
evice, hence this procedure is recommended to reduce
IAs and DWI lesions in flow-impairment cases.
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